ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

4,98
-0,23
(-4,41%)
Geschlossen 13 Juni 10:00PM
4,97
-0,01
(-0,20%)
Nach Börsenschluss: 1:59AM

Maravai LifeSciences Holdings Inc (MRVI) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
4,98
( -4,41% )
Gebot
4,90
Fragen
5,10
Volumen
1.675.512
4,9126 Tagesbereich 5,2483
1,99 52-Wochen-Bereich 5,30
Marktkapitalisierung
Handelsende
5,21
Handelsbeginn
5,20
Letzte Trade
1
@
4.98
Letzter Handelszeitpunkt
Finanzvolumen
US$ 8.387.468
VWAP
5,0059
Durchschnittliches Volumen (3 Mio.)
US$ 2.380.494
Ausgegebene Aktien
147.506.164
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-6,99
Gewinn pro Aktie (EPS)
-0,72
Erlöse (LTM)
204,73M
Nettogewinn (LTM)
-104,56M

Über Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operat... Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
San Diego, United States
Gegründet
2026
Maravai LifeSciences Holdings Inc is listed in the Healthcare sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was US$5,21. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 1,99 to US$ 5,30.

Maravai LifeSciences currently has 147.506.164 shares in issue. The market capitalisation of Maravai LifeSciences is US$734,58 million. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -6.99.

MRVI Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.01-0.2004008016034.995.34.88528017035.09108791CS
40.7718.28978622334.215.3428377304.70722222CS
121.9564.35643564363.035.32.824372984.08363916CS
261.2633.87096774193.725.32.818059283.84740008CS
522.76124.3243243242.225.31.9916655403.37745109CS
156-8.21-62.244124336613.1914.881.66521258655.94262709CS
260-40.12-88.957871396945.163.551.665199052413.69107988CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences Holdings Inc share price?
The current share price of Maravai LifeSciences Holdings Inc is US$ 4,98
How many Maravai LifeSciences Holdings Inc shares are in issue?
Maravai LifeSciences Holdings Inc has 147.506.164 shares in issue
What is the market cap of Maravai LifeSciences Holdings Inc?
The market capitalisation of Maravai LifeSciences Holdings Inc is USD 734,58M
What is the 1 year trading range for Maravai LifeSciences Holdings Inc share price?
Maravai LifeSciences Holdings Inc has traded in the range of US$ 1,99 to US$ 5,30 during the past year
What is the PE ratio of Maravai LifeSciences Holdings Inc?
The price to earnings ratio of Maravai LifeSciences Holdings Inc is -6,99
What is the cash to sales ratio of Maravai LifeSciences Holdings Inc?
The cash to sales ratio of Maravai LifeSciences Holdings Inc is 3,63
What is the registered address of Maravai LifeSciences Holdings Inc?
The registered address for Maravai LifeSciences Holdings Inc is 10770 Wateridge Circle, San Diego, California, 92121
What is the Maravai LifeSciences Holdings Inc website address?
The website address for Maravai LifeSciences Holdings Inc is www.maravai.com
Which industry sector does Maravai LifeSciences Holdings Inc operate in?
Maravai LifeSciences Holdings Inc operates in the Biotechnology & Life Sciences sector

MRVI Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen